ArticleClinical and experimental medicine2024

IL-21- and CXCL9-engineered GPC3-specific CAR-T cells combined with PD-1 blockade enhance cytotoxic activities against hepatocellular carcinoma.

Shanshan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.